Pick the relation: C = C₀·e−kt, LD = Vd·C/(S·F), maintenance rate = CL·Css/(S·F), τ = ln(Cpeak/Ctrough)/k.
For kidney function, estimate CrCl with Cockcroft–Gault first, then scale the dose or the interval.
Check the result: levels fall by half every half-life, and steady state takes about five half-lives.
2Practice problems
1.PharmacologyMedium
Patients taking metronidazole are usually advised to avoid:
ASunlight
BGrapefruit juice
CAlcohol
DDairy products
2.PharmacologyHard
A patient taking digoxin has nausea, yellow-green vision and a dangerous arrhythmia. Which specific treatment can bind the drug?
ADigoxin immune Fab (antibody fragments)
BFlumazenil
CIntravenous vitamin K (phytomenadione) given slowly
DProtamine sulfate
3.Dosage calculationsMedium
A child weighing 12 kg is prescribed 15 mg/kg of a drug. The stock solution contains 50 mg/mL. Draw up the dose: what volume V do you give?
12 kg15 mg/kg50 mg/mL
V = mL
4.Dosage calculationsHard
You must prepare 100 mL of a 0.5% (w/v) solution from a 25% (w/v) stock solution. What volume of stock V₁ do you need?
C₁ = 25%C₂ = 0.5%V₂ = 100 mL
V₁ = mL
5.Clinical pharmacokineticsMedium
Practice exercise (made-up values, not clinical guidance). After an IV dose of gentamicin, the level is 6 mg/L at 1 h and 0.8 mg/L at 11 h. Assume first-order elimination. Find the half-life t½.
C1 = 6 mg/L (1 h)C2 = 0.8 mg/L (11 h)
t½ = h
6.Clinical pharmacokineticsHard
Practice exercise (made-up values, not clinical guidance). A vancomycin infusion runs at 60 mg/h with no loading dose. The patient's clearance is 3 L/h and the half-life is 6 h. What is the level C after 10 h?
R = 60 mg/hCL = 3 L/ht½ = 6 ht = 10 h
C = mg/L
3Solutions
1.Pharmacology
Answer: C · Alcohol
Why this is the answer
Metronidazole can cause a disulfiram-like reaction with alcohol, with flushing, nausea and palpitations. Alcohol is avoided during treatment and for a short time after.
Answer
C · Alcohol
2.Pharmacology
Answer: A · Digoxin immune Fab (antibody fragments)
Why this is the answer
Digoxin immune Fab binds digoxin in the blood and makes it inactive. It is used for life-threatening toxicity, such as serious arrhythmias or severe hyperkalaemia.
Answer
A · Digoxin immune Fab (antibody fragments)
3.Dosage calculations
Answer: V = 3.6 mL
Drawing up a dose: volume = (prescribed dose/stock strength) × stock volume. Convert to the same units first, then check that the volume fits the syringe and lands on one of its graduations.
Dose from body weight
D = 15·12 = 180 mg
Volume
V = 180/50 = 3.6 mL
On the syringe
On this 10 mL syringe every small line is 0.2 mL.
Answer
V = 3.6 mL
4.Dosage calculations
Answer: V₁ = 2 mL
Solution strengths: a percentage strength is grams per 100 mL, so 1% = 1 g/100 mL = 10 mg/mL. A ratio strength 1:1000 means 1 g in 1000 mL = 1 mg/mL; 1:10 000 is 0.1 mg/mL. For a dilution the amount of drug stays the same: C₁·V₁ = C₂·V₂.
Volume of stock
V₁ = 0.5·100/25 = 2 mL
Answer
V₁ = 2 mL
5.Clinical pharmacokinetics
Answer: t½ = 3.44 h
Clearance and volume: at steady state the dosing rate equals the elimination rate, so the maintenance rate = CL × Css. A loading dose is LD = Vd × C/(S × F), with S the salt factor (fraction of active drug in the salt) and F the bioavailability (1 for IV). From two levels, k = ln(C₁/C₂)/Δt; for an IV bolus Vd = dose/C₀ and CL = k × Vd. The numbers are for practice only; at the bedside always follow local protocols and have high-risk doses double-checked.
Elimination rate constant
k = ln(6/0.8)/10 = 2.015/10 = 0.2015 h⁻¹
Half-life
t½ = 0.693/0.2015 = 3.44 h
Answer
t½ = 3.44 h
6.Clinical pharmacokinetics
Answer: C = 13.7 mg/L
Designing a regimen: with rapid IV doses the level falls from peak to trough during the interval, so τ = ln(Cpeak/Ctrough)/k and the dose that restores the peak is Vd × (Cpeak − Ctrough). The average steady-state level is Css,avg = S·F·dose/(CL·τ). An infusion rises as C = (R/CL)(1 − e−kt). For a drug cleared by the kidneys, the dose is scaled with the creatinine clearance. The numbers are for practice only; at the bedside always follow local protocols and have high-risk doses double-checked.